Sign In
Buy ANIK
$14.41
+0.0300 (+0.209%)
At Close: Jun 03, 2026
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 04'th Oct 2024
BEDFORD, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on October 1, 202
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:45pm, Monday, 09'th Sep 2024
BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 3,
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Thursday, 15'th Aug 2024
BEDFORD, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1, 2024
Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript
01:49am, Sunday, 11'th Aug 2024
Anika Therapeutics, Inc (NASDAQ:ANIK ) Q2 2024 Earnings Call August 8, 2024 5:00 PM ET Company Participants Mark Namaroff - Vice President, Investor Relations Cheryl Blanchard - President and Chief Ex
Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates
07:36pm, Thursday, 08'th Aug 2024
Anika Therapeutics (ANIK) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to loss of $0.19 per share a year ago.
Anika Reports Second Quarter 2024 Financial Results
04:05pm, Thursday, 08'th Aug 2024
Expanded Regenerative Solutions portfolio with full market release of the Integrity™ Implant System, a hyaluronic acid (HA)-based scaffold for rotator cuff and other tendon repairs, generating sig
Anika to Participate in the Sidoti Virtual Investor Conference
04:01pm, Monday, 05'th Aug 2024
BEDFORD, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will p
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
09:00am, Thursday, 25'th Jul 2024
BEDFORD, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:19am, Tuesday, 16'th Jul 2024
BEDFORD, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on July 1, 2024,
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika's proprietary hyaluronic acid (HA) regenerative portfolio
Advancements and Projections in the Orthopedic Regenerative Surgical Products Market: Insights, Trends, Opportunities, and Recent Developments Advancements and Projections in the Orthopedic Regenerati
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 07'th Jun 2024
BEDFORD, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3, 2024,
Anika Enters into Cooperation Agreement with Caligan Partners
04:05pm, Tuesday, 28'th May 2024
Appoints Joseph Capper and William Jellison to Board of Directors Announces New $40 Million Share Repurchase Program
Anika Therapeutics, Inc. (ANIK) Q1 2024 Earnings Call Transcript
11:36pm, Wednesday, 08'th May 2024
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q1 2024 Earnings Conference Call May 8, 2024 5:30 PM ET Company Participants Mark Namaroff - Vice President of Investor Relations, ESG and Corporate Communicati
Anika Announces CFO Transition
04:08pm, Wednesday, 08'th May 2024
Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024 Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024
